{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:14:54Z","timestamp":1782782094030,"version":"3.54.5"},"reference-count":14,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Newborn screening (NBS) for cystic fibrosis (CF) was introduced to London and South East England in 2007. We wished to assess the details of missed cases, and to compare the age at diagnosis and other clinical parameters, prescreening and postscreening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective and prospective case notes and database review of all newly diagnosed CF patients in our 7 CF centres, for 18\u2005months before and 4\u2005years after NBS started.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      347 patients were diagnosed with CF. 126 patients were not screened (born before or abroad), and had a median age at diagnosis of 2.4\u2005years, excluding those with meconium ileus (MI). Their median time to diagnosis from initial symptoms was 1 year, and in 10% it was &gt;6\u2005years. After NBS started, 170 were diagnosed by NBS (48% were already symptomatic); 7 moved into the region after NBS elsewhere; 34 presented with MI (6 were negative on NBS); and 10 screened children were missed (false negative cases). Median age of diagnosis was 3\u2005weeks. Prevalence was 1 in 3991 live births. By 2\u2005years of age (with data on 104 patients), 49 children (47%) had their first isolation of\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      , while 37 (36%) had their first growth of\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      from respiratory cultures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NBS has significantly reduced the age of diagnosis, although many were symptomatic even at 3\u2005weeks of age. A small number of patients with CF can still be missed by the screening programme, and the diagnosis should be considered even with a negative screen result.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2013-304766","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T01:01:52Z","timestamp":1384563712000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Diagnosis of cystic fibrosis in London and South East England before and after the introduction of newborn screening"],"prefix":"10.1136","volume":"99","author":[{"given":"MTC","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S B","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Chavasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I M","family":"Balfour-Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"key-10.1136\/archdischild-2013-304766-1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/adc.2007.115832","article-title":"Newborn screening for cystic fibrosis: evidence for benefit","volume":"93","author":"Balfour-Lynn","year":"2008","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2013-304766-2","unstructured":"UK Newborn Screening Programme Centre. A laboratory guide to newborn screening in the UK for cystic fibrosis (June 2009). http:\/\/newbornbloodspot.screening.nhs.uk\/nat_std_cf_protocol\/. (accessed 3 Feb 2013)."},{"key":"key-10.1136\/archdischild-2013-304766-3","first-page":"616","article-title":"Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols","volume":"52","author":"Gregg","year":"1993","journal-title":"Am J Hum Genet"},{"key":"key-10.1136\/archdischild-2013-304766-4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1542\/peds.99.6.819","article-title":"Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods","volume":"99","author":"Gregg","year":"1997","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2013-304766-5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/bmj.302.6787.1237","article-title":"Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis","volume":"302","author":"Ranieri","year":"1991","journal-title":"BMJ"},{"key":"key-10.1136\/archdischild-2013-304766-6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/adc.2005.081349","article-title":"Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing","volume":"91","author":"Massie","year":"2006","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2013-304766-7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/adc.2005.085084","article-title":"Newborn screening for cystic fibrosis: do we need a second IRT?","volume":"91","author":"Price","year":"2006","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2013-304766-8","unstructured":"UK Newborn Screening Programme Centre. Diagnostic outcome reports 2008\u201309, 2009\u201310, 2010\u201311. http:\/\/newbornbloodspot.screening.nhs.uk\/cms.php?folder=2607. (accessed 20 Feb 2013)."},{"key":"key-10.1136\/archdischild-2013-304766-9","unstructured":"Cystic Fibrosis Trust. UK CF Registry Annual Data Report 2011. http:\/\/www.cftrust.org.uk\/aboutcf\/publications\/cfregistryreports\/ (accessed 26 Feb 2013)."},{"key":"key-10.1136\/archdischild-2013-304766-10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcf.2011.10.002","article-title":"Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies","volume":"11","author":"Sanders","year":"2012","journal-title":"J Cyst Fibros"},{"key":"key-10.1136\/archdischild-2013-304766-11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jpeds.2006.07.026","article-title":"Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening","volume":"149","author":"Sontag","year":"2006","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2013-304766-12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/adc.77.6.493","article-title":"Incidence, population, and survival of cystic fibrosis in the UK, 1968\u201395. UK Cystic Fibrosis Survey Management Committee","volume":"77","author":"Dodge","year":"1997","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2013-304766-13","unstructured":"Data Management & Analysis update, May 2008. Birth projections by ethnicity for Greater London: 2007 Round PLP Low. http:\/\/www.london.gov.uk\/archive\/gla\/publications\/factsandfigures\/dmag-update-2008-09.pdf (accessed 21 Mar 2013)."},{"key":"key-10.1136\/archdischild-2013-304766-14","unstructured":"Office for National Statistics. Parents\u2019 country of birth, England and Wales, 2009. http:\/\/www.ons.gov.uk\/ons\/publications\/re-reference-tables.html?edition=tcm%3A77-39699 (accessed 26 Mar 2013)."}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-304766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:35:51Z","timestamp":1601094951000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-304766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,13]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1136\/archdischild-2013-304766"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-304766","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718178886.793506142","asserted-by":"object"}]},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}